tuberculosis WHO Updates Recommendations to Improve Access to Rapid MDx Tests for TB, Drug-Resistant TB The WHO recommended moderate-complexity, automated nucleic acid amplification test for the initial detection of TB and resistance to rifampicin and isoniazid. Wellcome Leap Launches $55M Program to Develop Disease-Specific Tissue Profiling Platforms The US nonprofit founded by the UK's Wellcome Trust will fund collaborative research projects to build multiscale and multimodal "tissue time machines." Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing Premium Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally. WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance The findings stem from a recent meeting of a WHO Guideline Development Group convened to address challenges with TB diagnosis and related drug-resistance. PerkinElmer to Buy Oxford Immunotec for $591M The deal will enable PerkinElmer to grow its infectious disease testing portfolio to include latent tuberculosis detection, it said. Dec 15, 2020 Imperial College London, Moredun Research Developing Silicon-Based Test for Infectious Disease Screening Premium Dec 9, 2020 Sequencing-Based Tuberculosis Drug Resistance Testing Gaining Momentum Premium Oct 15, 2020 Scanogen Developing Direct-From-Blood Infection Test That Could Provide Results in 90 Minutes Premium Oct 13, 2020 Qiagen Preliminary Q3 Revenues Up 26 Percent Sep 30, 2020 BARDA Exercises $10.5M Option on T2 Bio Contract Aug 13, 2020 Chinese Infectious Dx Firm Vision Medicals Completes $29M Series B Financing Round Aug 4, 2020 Qiagen Q2 Revenues Soar 16 Percent on Coronavirus Testing Product Sales Jul 17, 2020 Cepheid Debuts 10-Color Molecular Detection Technology With New Tuberculosis Test Premium Mar 24, 2020 GenoScreen Gets CE-IVD Mark for Tuberculosis Test Feb 20, 2020 Biological Dynamics Gets $1M Grant to Advance TB Test Feb 11, 2020 Biological Dynamics Aims to Boost Adoption of Raw Sample Biomarker Tech Through Microsoft Program Premium Jan 23, 2020 Ontera Developing Single-Pore Sensor for Sepsis, TB, and Zika Diagnostic Testing Premium Jan 20, 2020 Multi-Disease Diagnostic Platform Project Receives €22.5M in EU Funding Jan 13, 2020 JP Morgan Healthcare Day One: Qiagen, Guardant Health, Bio-Rad, Hologic, Myriad Genetics Dec 18, 2019 Rapid Diagnostics Resurrects Multiplex MiniLab Platform, Targets TB POC Test Premium Dec 3, 2019 Co-Diagnostics Joint Venture Gets Clearance in India for Five MDx Tests Sep 25, 2019 Chinese Biotech Startup Looks to Develop CRISPR-Based TB Diagnostic Premium Jul 25, 2019 UK Researchers Developing Blood-Based TB DNA Test, Eyeing Broader Screening Premium Jul 5, 2019 FIND, Unitaid Sign $14.5M Deal to Evaluate NGS-Based Diagnosis of Drug-Resistant TB Mar 22, 2019 Bruker TB Test, PCR Platform Receives CE-IVD Mark Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.